# Jin Zhang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jin-zhang-3/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,770 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 23 |
| i10-index | 40 |
| Last Known Institution | Shanghai Jiao Tong University |
| OpenAlex ID | https://openalex.org/A5100405908 |
| ORCID iD | 0000-0001-7241-0760 |
| Works | 91 |

## Researcher papers

- [Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pembrolizumab-for-the-treatment-of-non-small-cell-lung-cancer/)
- [Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial](https://scholariq.org/papers/adjuvant-capecitabine-with-docetaxel-and-cyclophosphamide-plus-epirubicin-for/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Extracellular vesicles in disease](https://scholariq.org/topics/extracellular-vesicles-in-disease/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.